BL Corp banner
B

BL Corp
KOSDAQ:142760

Watchlist Manager
BL Corp
KOSDAQ:142760
Watchlist
Price: 1 616 KRW -1.7% Market Closed
Market Cap: ₩63.1B

BL Corp
Investor Relations

BL Corp. engages in the development of biopharmaceutical products. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2014-11-26. The firm is engaged in the manufacture and sale of health functional foods and functional cosmetics. In addition, the Company is engaged in the distribution of pharmaceuticals and medical supplies. The firm is engaged in the distribution of Glu 100 Tablets, CellribonQ, and GentaQ and other medicine to general hospitals and pharmacies.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Park Young Chul
CEO & Chairman
No Bio Available
Mr. Hyun-Jae Sung
Chief Financial Officer and Senior Managing Director
No Bio Available
Mr. Chul-Joong Kim
Chief Technology Officer
No Bio Available
Kyung-Soo Hahm Ph.D.
Head of R&D Center
No Bio Available

Contacts

Address
GYEONGGI-DO
Yongin
7F, A Dong, Bundang Suji U Tower, 767, Sinsu-ro, Suji-gu
Contacts